MedTrace Logo

Two Year Follow up of Cadence Total Ankle Replacement

NCT03866642 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2019-03-07

No results posted yet for this study

Summary

Over the last decades, total ankle replacement (TAR) emerged as a reliable treatment option in end-stage ankle osteoarthritis (OA) while preserving motion and physiological load. The Cadence™ is a fourth-generation, two-component, fixed-bearing implant with minimal tibial and talar resection. It has been in clinical use since July 2016, the purpose of this study was to compare the clinical outcome and radiological outcomes of total ankle arthroplasty with use of the Cadence™ prosthesis at St. Michael's Hospital.

Conditions

  • Ankle Arthritis

Interventions

DEVICE

Cadence Total Ankle Replacment

Cadence Total Ankle prosthesis

Sponsors & Collaborators

  • Unity Health Toronto

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-01-05
Completion
2019-07-31
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03866642 on ClinicalTrials.gov